` DGX (Quest Diagnostics Inc) vs S&P 500 Comparison - Alpha Spread

DGX
vs
S&P 500

Over the past 12 months, DGX has significantly outperformed S&P 500, delivering a return of 31% compared to the S&P 500's 9% growth.

Stocks Performance
DGX vs S&P 500

Loading
DGX
S&P 500
Add Stock

Performance Gap
DGX vs S&P 500

Loading
DGX
S&P 500
Difference
www.alphaspread.com

Performance By Year
DGX vs S&P 500

Loading
DGX
S&P 500
Add Stock

Competitors Performance
Quest Diagnostics Inc vs Peers

Quest Diagnostics Inc
Glance View

Economic Moat
None
Market Cap
20.1B USD
Industry
Health Care

In the rapidly evolving world of healthcare, Quest Diagnostics Inc. stands as a pivotal player, shaping the future of diagnostic services. Born out of a quest for innovation in clinical testing, Quest Diagnostics operates at the intersection of medical science and cutting-edge technology. The company has a wide-reaching network of laboratories and service centers, offering a comprehensive array of diagnostic testing solutions that range from routine blood tests to advanced genetic screening. Their services are not limited to hospitals and physician offices; they extend into a variety of sectors including pharmaceuticals, food, and global business services, completing over a hundred million clinical laboratory tests annually. Quest's robust infrastructure and commitment to precision ensure that patients and healthcare providers receive timely and accurate information that is crucial for early detection, diagnosis, and informed treatment decisions. Quest Diagnostics' revenue model is straightforward yet effective, driven primarily by service fees from its expansive menu of tests. By collaborating with insurers, healthcare providers, and employers, Quest ensures broad access to its services. Moreover, the company continually invests in research and development to expand its test portfolio and enhance the quality of its services, thus staying competitive in the fast-paced healthcare environment. Through strategic acquisitions and partnerships, Quest has broadened its geographical reach and bolstered its technological capabilities, maintaining its position as an industry leader. As healthcare increasingly leans toward personalized medicine and preventive care, Quest Diagnostics is poised to leverage its analytical prowess and deep repository of health data to drive future growth and innovation, serving as an indispensable ally in global public health.

DGX Intrinsic Value
155.36 USD
Overvaluation 14%
Intrinsic Value
Price
Back to Top